Effects of a chitosan scaffold containing TGF-β1 encapsulated chitosan microspheres on in vitro chondrocyte culture

Artificial Organs

Volumn 28, Issue 9, 2004, Pages 829-839

  Jong, Eun Lee ^a   Seoung, Eun Kim ^b   Ick, Chan Kwon ^b   Hyun, Jeong Ahn ^a   Cho, Hyunchul ^a   Lee, Sang Hoon ^a   Hee, Joong Kim ^a   Sang, Cheol Seong ^a   Myung, Chul Lee ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

Cartilage; Chitosan; Chondrocyte; Controlled release; Growth factor; Microsphere; Scaffold; Tissue engineering

Indexed keywords

BODY FLUIDS; CHITOSAN; EMULSIFICATION; MICROSPHERES; SCAFFOLDS (BIOLOGY);

CHITOSAN MICROSPHERES; CHITOSAN SCAFFOLD; CHONDROCYTES; CHONDROGENIC POTENTIAL; CONTROLLED RELEASE; GROWTH FACTOR; IN-VITRO; TGF-Β1; TISSUES ENGINEERINGS; TRANSFORMING GROWTH FACTORS;

CARTILAGE;

CHITOSAN; GLYCOSAMINOGLYCAN; MICROSPHERE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DEGRADATION; DRUG EFFECT; DRUG POTENCY; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FREEZE DRYING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INCUBATION TIME; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAINING; STATISTICAL SIGNIFICANCE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 4344685878     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.00020.x     Document Type: Conference Paper

References (36)

1. Minas T, Nehrer S. Current concepts in the treatment of articular cartilage defects. Orthopedics 1997;20:525-38.
2. Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000;21:431-40.
3. Chandy T, Sharma CP. Chitosan - as a biomaterials. Biomater Artif Cell 1990;18:1-24.
4. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998;15:1326-31.
5. Madihally SV, Matthew HW. Porous chitosan scaffolds for tissue engineering. Biomaterials 1999;20:1133-42.
6. Lahiji A, Sohrabi A, Hungerford DS, Frondoza CG. Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res 2000;51:586-95.
7. Francis Suh JK, Howard WT. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials 2000;21:2589-98.
8. Mao JS, Zhao LG, Yin YJ, Yao KD. Structure and properties of bilayer chitosan-gelatin scaffolds. Biomaterials 2003;24:1067-74.
9. Cui YL, Qi AD, Liu WG, et al. Biomimetic surface modification of poly (1-lactic acid) with chitosan and its effects on articular chondrocytes in vitro. Biomaterials 2003;24:3859-68.
10. Ueno H, Nakamura F, Murakami M, Okumura M, Kadosawa T, Fujinag T. Evaluation effects of chitosan for the extracellular matrix production by fibroblasts and the growth factors production by macrophages. Biomaterials 2001;22:2125-30.
11. Sechriest VF, Miao YJ, Niyibizi C, et al. GAG-augmented polysaccharide hydrogel: a novel biocompatible and biodegradable material to support chondrogenesis. J Biomed Mater Res 2000;49:534-41.
12. Pei M, Seidel J, Vunjak-Novakovic G, Freed LE. Growth factors for sequential cellular de- and re-differentiation in tissue engineering. Biochem Biophys Res Commun 2002;294:149-54.
13. Elisseeff J, McIntosh W, Fu K, Blunk BT, Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001;19:1098-104.
14. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997;18:1201-25.
15. Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked chitosan beads: the influence of anion structure. Int J Pharm 2002;233:217-25.
16. Lee KY, Kwon IC, Kim YH, Jo WH, Jeong SY. Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998;51:213-20.
17. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999;5:387-91.
18. Chun KH, Kwon IC, Kim YH, La SB, Sohn YT, Jeong SY. Preparation of sodium alginate microspheres containing hydrophilic beta-lactam antibiotics. Arch Pharm Res 1996;19:106-16.
19. Cho NH, Seong SY, Chun KH, et al. Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. J Control Release 1998;53:215-24.
20. Shu XZ, Zuu KJ. Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. J Microencapsul 2001;18:237-45.
21. Jo H, Park JS, Kim EM, et al. The in vitro effects if dehydroepiandrosterone on human osteoarthritic chondrocytes. Osteoarthritis Cartilage 2003;11:585-94.
22. Buckwalter JA, Mankin HJ. Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect 1998;47:477-86.
23. Malemud CJ. The role of growth factors in cartilage metabolism. Rheum Dis Clin North Am 1993;19:569-80.
24. van Osch GJ, Mandl EW, Marijnissen WJ, van der Veen SW, Verwoerd-Verhoef HL, Verhaar JA. Growth factors in cartilage tissue engineering. Biorheology 2002;39:215-20.
25. Baldwin S, Saltzman W. Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 1998;33:71-86.
26. Kang HW, Tabata Y, Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999;20:1339-41.
27. Peter SJ, Lu L, Kim DJ, et al. Effects of transforming growth factor betal released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly (propylene fumarate) substrates. J Biomed Mater Res 2000;50:452-62.
28. Dinbergs ID, Brown L, Edelman ER. Cellular response to transforming growth factor-beta1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem 1996;271:29822-9.
29. Lu L, Stamatas GN, Mikos AG. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res 2000;50:440-51.
30. Hedberg EL, Tang A, Crowther RS, Carney DH, Mikos AG. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. J Control Release 2002;84:137-50.
31. Nof M, Shea LD. Drug-releasing scaffolds fabricated from drug-loaded microspheres. J Biomed Mater Res 2002;59:349-56.
32. Fortier LA, Nixon AJ, Mohammed HO, Lust G. Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1. Am J Vet Res 1997;58:66-70.
33. Denuziere A, Ferrier D, Damour O, Domard A. Chitosan-chondroitin sulfate and chitosan-hyaluronate polyelectrolyte complexes: biological properties. Biomaterials 1998;19:1275-85.
34. Muzzarelli RA, Zucchini C, Ilari P, et al. Osteoconductive properties of methylpyrrolidinone chitosan in an animal model. Biomaterials 1993;14:925-9.
35. Chou TC, Fu E, Shen EC. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochem Biophys Res Commun 2003;308:403-7.
36. Shibata Y, Foster LA, Metzger WJ, Myrvik QN. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 1997;65:1734-41.